Literature DB >> 8376763

Parameters of tolerance induction by antigen targeted to B lymphocytes.

E E Eynon1, D C Parker.   

Abstract

We have shown that a foreign protein Ag (the F(ab) fragment of rabbit IgG) becomes a particularly effective tolerogen when it is targeted to B lymphocytes in vivo. This is done by injecting the Ag intravenously into mice in the form of the F(ab) fragment of rabbit anti-mouse IgD antibody (F(ab)) rabbit anti-delta). Our hypothesis is that resting B cells are tolerogenic APC for CD4+ T cells in unprimed animals, and induce Ag-specific nonresponsiveness in the Th cell compartment by presenting Ag without appropriate costimulatory signals. In this report, we find that Ag-activated T cells appear to be resistant to tolerance induction, because F(ab) rabbit anti-delta given 5 days after challenge with rabbit F(ab) in alum adjuvant has little or no effect of the subsequent antibody response. Tolerance also fails in this model when B cells are activated independently of Ag by simultaneous injection of activating concentrations of divalent, IgG mouse anti-delta at the same time as F(ab) rabbit anti-delta. Finally, nonresponsiveness in the T cell compartment is not limited to a lesion in T cell help for the antibody response, because T cells from mice treated with F(ab) rabbit anti-delta and then primed with rabbit F(ab) fragments in CFA show reduced T cell proliferation and IL-2 production when restimulated with Ag in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice.

Authors:  Khairul Matin; M Abdus Salam; Joynab Akhter; Nobuhiro Hanada; Hidenobu Senpuku
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 3.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

4.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.

Authors:  J C Guery; F Galbiati; S Smiroldo; L Adorini
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

5.  Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells.

Authors:  K Bartnes; K Hannestad
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

6.  A role for inflammatory mediators in the induction of immunoregulatory B cells.

Authors:  Yumi Matsumura; Scott N Byrne; Dat X Nghiem; Yasuko Miyahara; Stephen E Ullrich
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

7.  Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.

Authors:  S W Chung; R M Gorczynski; I Dziadkowiec; G A Levy
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.

Authors:  Thomas Fehr; Sophia Wang; Fabienne Haspot; Josef Kurtz; Peter Blaha; Timothy Hogan; Meredith Chittenden; Thomas Wekerle; Megan Sykes
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 9.  Lupus autoantigens: their origins, forms, and presentation.

Authors:  H A Doyle; J Yan; B Liang; M J Mamula
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

Review 10.  Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens.

Authors:  W R Heath; C Kurts; J F Miller; F R Carbone
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.